1201 ORANGE STREET, WILMINGTON, DE
Awarded $11 Million Dollar DARPA Prime Contract to Evaluate Robotic Magnetic Stimulation in conjunction with NRX-101 for Treatment of Resistant Depression
Reports Update from the FDA Revising Previous Major Amendment to a Minor Amendment for Preservative-free Ketamine
Investor Presentation
Reports Second Quarter 2026 Financial Results and Provides Corporate Update; Conference Call to be Held on Monday, August 17th at 4:30pm ET
Reg. FD
Other Events
Announces Pricing of Public Offering of Common Stock
Announces Proposed Public Offering of Common Stock
Q1
Q3
Q2
Notice of Late Filing for Quarterly Report
Amended Annual Report
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Amended Registration Statement for Securities Offered under a Shelf Registration
RW
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Notification Filed by a National Security Exchange
Amended Schedule 13G - Ownership Report
Initial Statement of Beneficial Ownership
Statement of Changes in Beneficial Ownership
Prospectus filed pursuant to Rule 424(b)(7)
Correspondence
Submission Upload
Post-Effective Amendment to Registration Statement